EMP1 is an integral transmembrane glycoprotein, which has been identified as a poor prognostic factor in human cancers such as pediatric acute lymphoblastic leukemia, gliomas, gastric cancer, etc.28. Here, EMP1 is linked to central nervous system cancer.